TERRI BROWN: Open Payments
NPI 1053576405 · SULLIVAN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,874 in 66 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $1,827 · 2025 $1,874
Food & beverage: $1,575Education: $299
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $298 |
| Incyte Corporation | 2 | $228 |
| SEAGEN INC. | 2 | $199 |
| PFIZER INC. | 14 | $186 |
| Merck Sharp & Dohme LLC | 8 | $155 |
| GlaxoSmithKline, LLC. | 3 | $140 |
| Geron Corporation | 2 | $100 |
| Eisai Inc. | 4 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
Products named: RYBREVANT, KEYTRUDA, Monjuvi, ZEJULA, RYTELO, Lenvima, FRUZAQLA, ELIQUIS.
Industry payments across IN — which companies pay providers there.
